Literature DB >> 18584330

Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.

Lisa R Tannock1, Victoria L King.   

Abstract

The response to retention hypothesis outlines the initial stages of atherosclerotic lesion formation. The central theme of the hypothesis is that proteoglycan mediated lipoprotein retention plays a critical step in the initiation of atherosclerosis development. Recent research using human arterial specimens, transgenic mouse models and molecular biology techniques have added to our understanding of atherosclerosis development, and provided experimental data in support of the response to retention hypothesis. In this review we summarize the recent data, in particular that which addresses mechanisms by which diabetes can accelerate atherosclerosis formation, with a focus on proteoglycan-mediated LDL retention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584330     DOI: 10.1007/s11154-008-9078-0

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  110 in total

Review 1.  Transforming growth factor beta in diabetic nephropathy.

Authors:  W A Border; T Yamamoto; N A Noble
Journal:  Diabetes Metab Rev       Date:  1996-12

2.  Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.

Authors:  H C Stary
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

3.  Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.

Authors:  A Bobik; A Agrotis; P Kanellakis; R Dilley; A Krushinsky; V Smirnov; E Tararak; M Condron; G Kostolias
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

4.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  Ultrastructure of early lipid accumulation in ApoE-deficient mice.

Authors:  M Tamminen; G Mottino; J H Qiao; J L Breslow; J S Frank
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

6.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

Authors:  H M Dansky; S A Charlton; M M Harper; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 7.  Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.

Authors:  S-O Olofsson; J Borèn
Journal:  J Intern Med       Date:  2005-11       Impact factor: 8.989

8.  Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.

Authors:  Mariam Rodríguez-Lee; Gunnel Ostergren-Lundén; Boel Wallin; Jonatan Moses; Göran Bondjers; Germán Camejo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-20       Impact factor: 8.311

9.  Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.

Authors:  L E Cardoso; P A Mourão
Journal:  Arterioscler Thromb       Date:  1994-01

10.  Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells.

Authors:  E Schönherr; H T Järveläinen; L J Sandell; T N Wight
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

View more
  15 in total

1.  Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.

Authors:  Joanne M Ajmo; Lauren A Bailey; Matthew D Howell; Lisa K Cortez; Keith R Pennypacker; Hina N Mehta; Dave Morgan; Marcia N Gordon; Paul E Gottschall
Journal:  J Neurochem       Date:  2010-02-17       Impact factor: 5.372

2.  Hyperglycemia impairs atherosclerosis regression in mice.

Authors:  Nathalie Gaudreault; Nikit Kumar; Victor R Olivas; Delphine Eberlé; Kyle Stephens; Robert L Raffai
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

3.  Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice.

Authors:  Tao Tang; Patricia G Wilson; Joel C Thompson; Christina Nelson; Meghan H Yoder; Lisa R Tannock
Journal:  J Lipid Res       Date:  2013-06-07       Impact factor: 5.922

4.  Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Authors:  Joel Thompson; Patricia Wilson; Katie Brandewie; Deepa Taneja; Liliana Schaefer; Bonnie Mitchell; Lisa R Tannock
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

5.  Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.

Authors:  Michael E Yeager; Kelley L Colvin; Allen D Everett; Kurt R Stenmark; D Dunbar Ivy
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

6.  Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia.

Authors:  Shobini Jayaraman; Olivia R Chavez; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-04-11       Impact factor: 4.698

7.  A murine model of obesity with accelerated atherosclerosis.

Authors:  Victoria L King; Nicholas W Hatch; Huei-Wei Chan; Marcielle C de Beer; Frederick C de Beer; Lisa R Tannock
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

8.  Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1.

Authors:  Neeta Adhikari; Marie Billaud; Marjorie Carlson; Spencer P Lake; Kim Ramil C Montaniel; Rod Staggs; Weihua Guan; Dinesha Walek; Snider Desir; Brant E Isakson; Victor H Barocas; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

Review 9.  [Update on diabetic macroangiopathy].

Authors:  J Kunz
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

10.  The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions.

Authors:  Shengya Tian; Yang Cao; Jinliang Wang; Yongjun Bi; Jingquan Zhong; Xiangbin Meng; Wenyu Sun; Ruixue Yang; Luping Gan; Xuping Wang; Hongshi Li; Rong Wang
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.